Eileen obtained her Master’s degree in Pharmacy at Utrecht University, after which she completed a four-year hospital pharmacy residency at the Leiden University Medical Center (LUMC). In parallel, she pursued a PhD in collaboration with the Willem Alexander Children’s Hospital, focusing on pediatric allogeneic stem cell transplantation.

She now works as a hospital pharmacist at the LUMC, where she combines her clinical background with a strong focus on the development and manufacturing of advanced therapies. She specializes in the production of ATMP’s and infectious challenge agents used in Controlled Human Infection Models (CHIMs). Her work supports early-phase clinical research into diseases such as malaria, schistosomiasis, hookworm, Clostridium difficile, and COVID-19, bridging pharmaceutical development with public health impact.